Belantamab Mafodotin
Drug timelines are a Plus or Pro feature.
22 regulatory and trial events tracked for Belantamab Mafodotin, covering 2020-04-28 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis [Phase 2]